Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,192Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Betamethasone could improve outcomes for prostate cancer radiation therapy
    Betamethasone could improve outcomes for prostate cancer radiation therapy

    12 Aug 2022

    // NEWSWIRE

    https://www.newswise.com/articles/betamethasone-could-improve-outcomes-for-prostate-cancer-radiation-therapy#:~:text=Betamethasone%20could%20improve%20outcomes%20for%20prostate%20cancer%20radiation%20therapy,-Released%3A%2012%2DAug&text=Newswise%20%E2%80%94%20A%20new%20study%20published,radiation%20treatments%20for%20prostate%20cancer.

    NEWSWIRE
    12 Aug 2022
    Share Share
    Fagron Group B.V. Receives FDA Warning Letter
    Fagron Group B.V. Receives FDA Warning Letter

    29 Jun 2022

    // FDA

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fagron-group-bv-624255-06142022

    FDA
    29 Jun 2022
    Share Share
    Padagis Announces 3 Major Product Launches
    Padagis Announces 3 Major Product Launches

    21 Jun 2022

    // FDA

    https://padagis.com/padagis-announces-3-major-product-launches/

    FDA
    21 Jun 2022
    Share Share
    Glenmark receives ANDA approval for topical treatment of plaque psoriasis
    Glenmark receives ANDA approval for topical treatment of plaque psoriasis

    09 May 2022

    // ET HEALTH

    https://health.economictimes.indiatimes.com/news/pharma/glenmark-receives-anda-approval-for-topical-treatment-of-plaque-psoriasis-in-adults/91434978

    ET HEALTH
    09 May 2022
    Share Share
    Enforcement Report - Week of September 22, 2021
    Enforcement Report - Week of September 22, 2021

    22 Sep 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-22-2021-1632297403.pdf

    FDA
    22 Sep 2021
    Share Share
    EPI Health and MC2 Therapeutics announces U.S. Launch of Wynzora
    EPI Health and MC2 Therapeutics announces U.S. Launch of Wynzora

    19 Jul 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/epi-health-and-mc2-therapeutics-announces-us-launch-of-wynzora-cream-for-plaque-psoriasis-calcipotriene-and-betamethasone-dipropionate-ww-0-0050-064-301332247.html

    PRNEWSWIRE
    19 Jul 2021
    Share Share